SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Incara Pharmaceuticals Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
45325 S-10-1 (CUSIP Numbers) |
December 31, 2003
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No.
1. | Name of Reporting Person I.R.S. Identification No. of above persons (entities only)
Lola M. Reid |
|||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
Not Applicable (a) ¨ (b) ¨ |
|||
3. | SEC Use Only
|
|||
4. | Citizenship or Place of Organization
United States |
|||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5. Sole Voting Power
427,986 6. Shared Voting Power
315,664 7. Sole Dispositive Power
427,986 8. Shared Dispositive Power
315,664 | |
9. | Aggregate Amount Beneficially Owned by Each Reporting Person
743,650 |
|||
10. | Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ |
|||
11. | Percent of Class Represented by Amount in Row (9)
1.6% |
|||
12. | Type of Reporting Person (See Instructions)
IN |
|||
Item 1 |
(a) |
Name of Issuer | ||||||||||
Incara Pharmaceuticals Corporation | ||||||||||||
Item 1 |
(b) |
Address of Issuers Principal Executive Offices | ||||||||||
79 T.W. Alexander Dr., 4401 Research Commons, Suite 200, P.O. Box 14287, Research Triangle Park, NC 27709-4287 |
||||||||||||
Item 2 |
(a) |
Name of Person Filing | ||||||||||
Lola M. Reid | ||||||||||||
Item 2 |
(b) |
Address of Principal Business Office, or, if none, Residence | ||||||||||
79 T.W. Alexander Dr., 4401 Research Commons, Suite 200, P.O. Box 14287, Research Triangle Park, NC 27709-4287 |
||||||||||||
Item 2 |
(c) |
Citizenship | ||||||||||
UnitedStates |
||||||||||||
Item 2 |
(d) |
Title of Class of Securities: | ||||||||||
CommonStock |
||||||||||||
Item 2 |
(e) |
CUSIP Number: | ||||||||||
45325 S-10-1 | ||||||||||||
Item 3. |
Filing pursuant to Rules 13d-1(b), or 13d-2(b) | |||||||||||
Not Applicable | ||||||||||||
Item 4. |
Ownership. | |||||||||||
(a) | As of December 31, 2003, Dr. Reid beneficially owned an aggregate of 743,650 shares of the Issuers Common Stock which includes (i) 316,786 shares owned by Dr. Reid, (ii) 237,478 shares owned by Dr. Reids husband, (iii) 110,000 shares issuable upon exercise of options held by Dr. Reid, (iv) 78,186 shares issuable upon exercise of options held by Dr. Reids husband and (v) 1,200 shares issuable upon exercise of warrants held by Dr. Reid. Dr. Reid disclaims beneficial ownership of the shares held by her husband. |
(b) | Percent of class: 1.6%. This final Schedule 13G is being filed because the ownership has decreased to less than 5% due to the issuance of additional shares of common stock by Incara Pharmaceuticals Corporation. | |||||||||||
(c) | Number of shares as to which such person has: | |||||||||||
(i) | Sole power to vote or to direct the vote: 427,986 | |||||||||||
(ii) | Shared power to vote or to direct the vote: 315,664 | |||||||||||
(iii) | Sole power to dispose or to direct the disposition of: 427,986 | |||||||||||
(iv) | Shared power to dispose or to direct the disposition of: 315,664 | |||||||||||
Item 5. |
Ownership of Five Percent or Less of a Class | |||||||||||
Not Applicable | ||||||||||||
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person | |||||||||||
Not Applicable | ||||||||||||
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company | |||||||||||
Not Applicable | ||||||||||||
Item 8. |
Identification and Classification of Members of the Group | |||||||||||
Not Applicable | ||||||||||||
Item 9. |
Notice of Dissolution of Group | |||||||||||
Not Applicable | ||||||||||||
Item 10. |
Certification | |||||||||||
Not Applicable |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 17, 2004 |
Date |
/s/ Lola M. Reid |
Lola M. Reid |